Results 21 to 30 of about 2,310,180 (194)

The Association of Real-World CA 19-9 Level Monitoring Patterns and Clinical Outcomes Among Patients With Metastatic Pancreatic Ductal Adenocarcinoma

open access: yesFrontiers in Oncology, 2021
BackgroundPancreatic cancer is expected to be the third deadliest cancer in the US in 2021. Evaluation of treatment response in patients with mPDAC necessitates scheduled clinical and radiographic assessments along with monitoring serum CA 19-9 levels ...
Ben George   +4 more
doaj   +1 more source

Transient Elevation of CA 19-9 Due to Cessation of Levothyroxine in a Patient with Hashimoto’s Thyroiditis

open access: yesEndocrinology Research and Practice, 2019
Serum CA 19-9 (carbohydrate antigen 19-9) is a tumor marker with monosialoganglioside structure. Its levels are measured frequently for screening purposes in daily practice by physicians, while its main application is in the study of tumor recurrence and
Arzu OR KOCA, Mustafa ALTAY
doaj   +1 more source

Utilization and Effectiveness of the CA 19-9 Test for Cancer Diagnosis: Insights from Health Ministry Records

open access: yesİstanbul Medical Journal, 2023
Introduction:This retrospective study evaluated the use and findings of the CA 19-9 test in the diagnosis of pancreatic cancer.Methods:The study analyzed data from a large population of 2,981,142 individuals who underwent CA 19-9 testing between 2017 and
Mustafa Mahir Ülgü, Şuayip Birinci
doaj   +1 more source

Elevated CEA and CA 19-9 Levels within the Normal Ranges Increase the Likelihood of CRC Recurrence in the Chinese Han Population

open access: yesApplied Bionics and Biomechanics, 2022
Objective. This study aimed to determine if variations in the expression profiles of CA 19-9 and carcinoembryonic antigen (CEA) within the reference range could serve as possible biomarkers for postoperative CRC recurrence. Method.
Lujia Wang   +4 more
doaj   +1 more source

Elevated CA 19-9 Levels in Mature Cystic Teratoma of the Ovary

open access: yesThe International Journal of Biological Markers, 2009
The purpose of this study was to evaluate the clinical value of serum tumor markers in patients with ovarian mature cystic teratoma (MCT). We retrospectively evaluated 163 women who underwent surgery for MCT of the ovary between March 2003 and August ...
Min Sun Kyung   +3 more
doaj   +1 more source

Pancreatic Tuberculosis with Markedly Elevated CA 19-9 Levels: A Diagnostic Pitfall

open access: yesOman Medical Journal, 2016
Despite the high prevalence of tuberculosis (TB) in developing countries, isolated pancreatic TB is rare and is usually seen in immunocompromised patients.
Manveen Kaur   +3 more
doaj   +1 more source

Impact of Radiation Therapy on Physical and Psychosocial Health of Adolescents and Young Adults: A Joint Report From the Children's Oncology Group AYA and Radiation Oncology Committees

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Rates of cancer among adolescents and young adults (AYA), age 15–39 years, are increasing. Consequently, radiation oncologists are treating more AYAs who have diagnoses spanning both pediatric and adult practices. Compared to pediatric and older adult patients, AYAs face a unique set of challenges.
Hesham Elhalawani   +7 more
wiley   +1 more source

Prognostic Significance of CEA and CA 19–9 inc Colorectal Cancer in Kuwait

open access: yesThe International Journal of Biological Markers, 2000
Preoperative CEA and CA 19–9 levels have been used in the past as prognostic indicators in colorectal cancer, but Dukes’ stage is still considered to be the most important prognostic factor.
A.I. Behbehani   +6 more
doaj   +1 more source

Clinical significance of serum follistatin levels in the diagnosis of ovarian endometrioma and benign ovarian cysts

open access: yesTaiwanese Journal of Obstetrics & Gynecology, 2015
Objective: To determine the clinical significance of serum follistatin levels in women with an ovarian endometrioma. Materials and methods: This is a prospective study of 89 women, 56 with an ovarian endometrioma (endometrioma group) and 33 with a benign
Ömer Ant   +5 more
doaj   +1 more source

Pediatric Idiopathic Multicentric Castleman Disease Is Often Severe But Responsive to Siltuximab

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Idiopathic multicentric Castleman disease (iMCD) is a potentially fatal immunologic disorder marked by widespread lymphadenopathy and inflammation. Siltuximab, an interleukin‐6 (IL‐6) inhibitor, is the only FDA‐approved treatment for adult patients with iMCD.
Bridget Austin   +17 more
wiley   +1 more source

Home - About - Disclaimer - Privacy